By Izzy Wood (Drug Target Review)2023-02-01T13:50:02
Chronic pain often leads to depression, which US researchers have potentially solved using a mechanism involved with ketamine.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-26T13:22:42
Sponsored by bit.bio
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-09-27T13:56:39
Sponsored by Euretos
2023-11-24T12:06:45
Sponsored by Quantum-Si
Site powered by Webvision Cloud